Global Eubiotics Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Type;
Probiotics - [Lactobacilli, Bifidobacteria and Others], Prebiotics - [Inulin, Fructo-Oligosaccharides, Galacto-Oligosaccharides and Others], Organic Acids, and Essential OilsBy Animal Type;
Ruminant, Poultry, Swine, Aquaculture, and OthersBy Form;
Liquid and SolidBy End Use;
Cattle Feed, Poultry Feed, Swine Feed, Aquatic Feed, and OthersBy Geography;
North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)Eubiotics MarketOverview
Eubiotics Market (USD Million)
Eubiotics Market was valued at USD 5,362.23 million in the year 2024. The size of this market is expected to increase to USD 9,430.84 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 8.4%.
Global Eubiotics Market Growth, Share, Size, Trends and Forecast
*Market size in USD million
CAGR 8.4 %
Study Period | 2025 - 2031 |
---|---|
Base Year | 2024 |
CAGR (%) | 8.4 % |
Market Size (2024) | USD 5,362.23 Million |
Market Size (2031) | USD 9,430.84 Million |
Market Concentration | Medium |
Report Pages | 399 |
Major Players
- BASF SE
- Cargill Incorporated
- Novozymes
- E. I. du Pont de Nemours and Company
- Kemin Industries Inc
- Lallemand Inc
- Koninklijke DSM NV
- Chr. Hansen Holding AS
- Addcon
- Novus International Inc
Market Concentration
Consolidated - Market dominated by 1 - 5 major players
Global Eubiotics Market
Fragmented - Highly competitive market without dominant players
The eubiotics market is experiencing notable growth driven by increasing emphasis on gut health and digestive support. Eubiotics—such as probiotics, prebiotics, and organic acids play a vital role in maintaining a healthy balance of intestinal microflora. With rising interest in natural health solutions, over 55% of manufacturers are incorporating these compounds to enhance overall wellness and reduce dependence on synthetic additives.
Movement Toward Antibiotic-Free Solutions
There is a significant transition toward antibiotic-free nutrition, especially in animal feed. Concerns over antimicrobial resistance and tighter regulations have led nearly 48% of livestock producers to adopt natural feed additives like eubiotics. This shift reflects a broader industry trend favoring safer, more sustainable ways to boost animal performance and health outcomes.
Rising Integration in Health Supplements and Foods
In the human health sector, eubiotics are gaining ground across functional food and dietary supplement categories. As consumers increasingly seek natural immune and gut health boosters, around 40% of recent product innovations now include eubiotic ingredients. Their benefits in supporting metabolism, immunity, and digestion are aligning well with the growing demand for proactive and personalized wellness options.
Favorable Policies and Research Investments
Supportive regulatory frameworks and strong research backing are further propelling market expansion. Approximately 42% of ongoing nutrition-focused R&D projects now center on eubiotic innovations, encouraged by policies that promote sustainable health solutions. These efforts are creating a solid foundation for continued growth and increased adoption across various health and nutrition sectors.
Eubiotics Market Recent Developments
-
In 2022, Lesaffre acquired biotech innovator Recombia Biosciences, leveraging its genome‑editing and synthetic biology capabilities to accelerate innovation in next‑gen yeast and eubiotics solutions.
-
In March 2024, Novus International acquired BioResource International Inc., adding its enzyme‑based products, IP, and facilities to enhance its gut‑health eubiotics portfolio and innovation pipeline.
Eubiotics Market Segment Analysis
In this report, the Eubiotics Market has been segmented by Type, Animal Type, Form, End User, and Geography.
Eubiotics Market, Segmentation by Type
The Eubiotics Market has been segmented by Type into Probiotics - Lactobacilli, Bifidobacteria and Others, Prebiotics - Inulin, Fructo-oligosaccharides, Galacto-oligosaccharides and Others, Organic Acids and Essential Oils.
Probiotics - Lactobacilli, Bifidobacteria and Others
The probiotics segment, particularly strains like Lactobacilli and Bifidobacteria, is witnessing rapid growth due to rising consumer demand for gut health and immune-boosting supplements. Probiotics account for over 35% of the overall eubiotics market. Their application in animal feed and human dietary products is significantly influencing the segment's momentum.
Prebiotics - Inulin, Fructo-oligosaccharides, Galacto-oligosaccharides and Others
Prebiotics, such as inulin, fructo-oligosaccharides (FOS), and galacto-oligosaccharides (GOS), foster the growth of beneficial gut bacteria. This segment contributes approximately 25% to the total market and is expanding due to increasing awareness about non-digestible fibers and their benefits in gut microbiota modulation.
Organic Acids
The organic acids segment holds a significant share in the eubiotics market, valued at nearly 20%. These compounds are extensively used in livestock feed to inhibit pathogen growth and enhance nutrient absorption. The demand is being driven by their effectiveness in improving gut health without contributing to antibiotic resistance.
Essential Oils
Essential oils, derived from natural plant sources, are gaining popularity for their antimicrobial and antioxidant properties. They represent around 15% of the market and are increasingly used as feed additives in poultry and swine nutrition. The growing preference for natural and chemical-free additives is propelling this segment forward.
Eubiotics Market, Segmentation by Animal Type
The Eubiotics Market has been segmented by Animal Type into Ruminant, Poultry, Swine, Aquaculture, and Others.
Ruminant
The ruminant segment, which includes cattle and sheep, uses eubiotics to enhance digestion and improve feed efficiency. With rising demand for high-quality dairy and meat products, the adoption of probiotics and organic acids in ruminant feed is increasing steadily. This segment accounts for nearly 30% of the total market share.
Poultry
The poultry segment is the largest consumer of eubiotics, driven by the need to improve gut health, enhance immunity, and reduce dependency on antibiotics. Over 35% of the eubiotics market is attributed to poultry applications, particularly in broilers and layers for optimized growth performance.
Swine
Swine producers are increasingly incorporating eubiotics to prevent gastrointestinal diseases and enhance nutrient absorption. This segment contributes about 20% to the market. The use of essential oils and prebiotics is gaining traction for promoting growth in weaning piglets.
Aquaculture
Aquaculture is an emerging segment in the eubiotics market, witnessing growth due to the demand for sustainable aquatic farming. The use of prebiotics and probiotics helps maintain water quality and supports fish gut microbiota. It comprises approximately 10% of the market share.
Others
This category includes pets and
Eubiotics Market, Segmentation by Form
The Eubiotics Market has been segmented by Form into Liquid, and Solid.
Liquid
The liquid form of eubiotics is favored for its ease of mixing in feed and faster absorption in the digestive tract. It is widely used in intensive livestock production systems. Accounting for nearly 40% of the market, liquid eubiotics are especially popular in poultry and swine applications.
Solid
Solid eubiotics, such as powders and granules, dominate the market with a share of around 60%. These are preferred due to their longer shelf life and ease of storage and transport. Solid forms are extensively used across all major animal categories, including ruminants and aquaculture.
Eubiotics Market, Segmentation by End User
The Eubiotics Market has been segmented by End User into Cattle Feed, Poultry Feed, Swine Feed, Aquatic Feed, and Others
Cattle Feed
The cattle feed segment uses eubiotics to enhance rumen function and improve feed conversion efficiency. With growing dairy and beef consumption, the demand for organic acids and probiotics in cattle nutrition has risen. This segment represents nearly 30% of the total market.
Poultry Feed
Poultry feed is the leading end-use segment, driven by the global expansion of broiler and layer farming. Over 35% of eubiotic consumption comes from this sector, focusing on gut health and improved immunity. Both prebiotics and essential oils are widely used in poultry diets.
Swine Feed
In swine feed, eubiotics play a vital role in reducing post-weaning stress and boosting nutrient uptake. This segment accounts for approximately 20% of the market. Increasing bans on antibiotics are accelerating the shift toward natural growth promoters like probiotics and acidifiers.
Aquatic Feed
Aquatic feed applications are growing rapidly as aquaculture expands globally. Eubiotics help in enhancing disease resistance and improving nutrient utilization in fish and shrimp. Aquatic feed holds a market share of around 10% and is expected to grow steadily in the coming years.
Others
This category includes pet food and feed for niche livestock species. Though currently limited in market share, the use of eubiotics in these areas is expected to grow as consumers demand more natural additives in specialty animal nutrition products.
Eubiotics Market, Segmentation by Geography
In this report, the Eubiotics Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Regions and Countries Analyzed in this Report
Eubiotics Market Share (%), by Geographical Region
North America
North America holds a significant share in the eubiotics market due to high awareness about antibiotic-free animal feed and established livestock industries. The United States leads the region, supported by advanced farming practices and a growing demand for natural feed additives.
Europe
Europe is a mature market for eubiotics, driven by stringent regulations on antibiotic use and strong focus on sustainable livestock production. Countries like Germany, France, and the Netherlands are key contributors, with increasing adoption of prebiotics and probiotics.
Asia Pacific
Asia Pacific is the fastest-growing region, fueled by the rising population, expanding meat industry, and growing demand for high-quality animal protein. China and India are major markets, with a strong push for feed efficiency and animal health improvement using eubiotics.
Middle East and Africa
The Middle East and Africa are emerging markets with increasing investment in animal husbandry and growing awareness of livestock productivity. Though currently smaller in size, the region shows potential for steady growth in the coming years.
Latin America
Latin America, particularly Brazil and Argentina, is witnessing increased adoption of eubiotics due to the expansion of the poultry and swine industries. Government support and a shift toward antibiotic alternatives are further driving market development in this region.
`Eubiotics Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Eubiotics Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Comprehensive Market Impact Matrix
This matrix outlines how core market forces—Drivers, Restraints, and Opportunities—affect key business dimensions including Growth, Competition, Customer Behavior, Regulation, and Innovation.
Market Forces ↓ / Impact Areas → | Market Growth Rate | Competitive Landscape | Customer Behavior | Regulatory Influence | Innovation Potential |
---|---|---|---|---|---|
Drivers | High impact (e.g., tech adoption, rising demand) | Encourages new entrants and fosters expansion | Increases usage and enhances demand elasticity | Often aligns with progressive policy trends | Fuels R&D initiatives and product development |
Restraints | Slows growth (e.g., high costs, supply chain issues) | Raises entry barriers and may drive market consolidation | Deters consumption due to friction or low awareness | Introduces compliance hurdles and regulatory risks | Limits innovation appetite and risk tolerance |
Opportunities | Unlocks new segments or untapped geographies | Creates white space for innovation and M&A | Opens new use cases and shifts consumer preferences | Policy shifts may offer strategic advantages | Sparks disruptive innovation and strategic alliances |
Drivers, Restraints and Opportunities Analysis
Drivers
- Ban on antibiotic growth promoters
- Rising demand for natural feed additives
- Growing awareness of animal gut health
-
Expansion of livestock and poultry farming - A critical factor driving the growth of the eubiotics market. As global demand for meat, eggs, and dairy products rises, farmers are intensifying their production practices. This shift is increasing the focus on animal gut health, feed efficiency, and immunity, all of which are supported by the application of eubiotics in feed.
In both developed and developing countries, growth in animal agriculture is leading to larger herds and denser populations, creating a need for natural growth promoters and disease prevention strategies. Eubiotics, which include probiotics, prebiotics, essential oils, and organic acids, are being used to improve nutrient absorption, reduce antibiotic usage, and maintain optimal intestinal microbiota balance in livestock.
Increasing consumer demand for antibiotic-free and sustainably raised animal products is further encouraging the adoption of eubiotic-based feed solutions. With greater scrutiny on food safety and production transparency, livestock operators are turning to biologically active feed additives that enhance both productivity and animal welfare. This trend is particularly prominent in poultry and swine sectors, which require fast weight gain and high feed conversion ratios.
Governments and regulatory bodies are also supporting the responsible intensification of livestock farming through subsidies, guidelines, and research incentives. As more integrated farming systems adopt performance-enhancing feed technologies, eubiotics are becoming a preferred choice in ensuring sustainable animal production and long-term profitability.
Restraints
- High cost of eubiotic formulations
- Regulatory hurdles across different regions
- Limited penetration in developing economies
-
Lack of standardized efficacy benchmarks - A major restraint affecting the growth of the eubiotics market. Unlike antibiotics or chemical additives, eubiotic products vary widely in composition, dosage, and performance across different species and environments. This variability makes it difficult for producers and farmers to rely on consistent results, leading to skepticism about return on investment.
There is currently no global regulatory consensus on efficacy validation methods for eubiotics, which creates uncertainty among buyers and limits the pace of market adoption. Variations in gut microbiota, regional feed compositions, and management systems further complicate comparative evaluations. The absence of clear benchmarks makes it challenging to design trials, standardize dosages, and measure effectiveness.
This issue is particularly acute for smaller producers who may lack the technical resources to conduct comprehensive studies. In addition, inconsistent labeling and marketing claims can confuse consumers and damage credibility across the category. Without robust data, it is difficult for stakeholders to demonstrate the scientific and economic value of eubiotic supplementation.
This barrier, there is a growing need for collaborative industry frameworks, regulatory harmonization, and investment in field-based research. Establishing clear and repeatable metrics would build confidence among feed formulators and animal nutritionists, thereby accelerating the integration of eubiotics into mainstream livestock feeding programs.
Opportunities
- Innovation in multi-strain probiotic blends
- R&D in microbiome-based feed solutions
- Rising organic and antibiotic-free meat demand
-
Expansion into aquaculture and companion animals - A significant opportunity for the eubiotics market. With the aquaculture industry experiencing rapid growth, there is an increasing need for sustainable, antibiotic-free methods to maintain fish health, improve growth rates, and reduce mortality. Eubiotics offer a promising solution by enhancing intestinal microbiota balance and immune responses in aquatic species.
Innovations in delivery mechanisms, such as microencapsulation and water-stable formulations, are making eubiotic products more effective and commercially viable for fish and shrimp farming. These advancements support improved feed conversion ratios and disease resistance, which are vital for profitability in high-density aquatic environments. As environmental concerns intensify, eubiotics are also helping to reduce water contamination and antibiotic discharge.
Meanwhile, the rising global pet population and humanization of pets are creating a booming market for functional supplements in companion animals. Eubiotics are increasingly being used to address digestive health, allergies, and immune support in dogs and cats. Pet owners are seeking natural and scientifically supported ingredients in their pet's diet, making eubiotics an attractive product category.
This dual-sector opportunity enables companies to diversify their revenue streams and leverage cross-species research for product innovation. As the pet and aquaculture sectors demand higher quality, sustainability, and traceability, eubiotics are well-positioned to meet these needs and foster long-term market expansion.
Eubiotics Market Competitive Landscape Analysis
Key players in Eubiotics Market include:
- BASF SE
- Cargill Incorporated
- Novozymes
- E. I. du Pont de Nemours and Company
- Kemin Industries Inc
- Lallemand Inc
- Koninklijke DSM NV
- Chr. Hansen Holding AS
- Addcon
- Novus International Inc
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Market Share Analysis
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Animal Type
- Market Snapshot, By Form
- Market Snapshot, By End Use
- Market Snapshot, By Region
- Eubiotics Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Ban on antibiotic growth promoters
- Rising demand for natural feed additives
- Growing awareness of animal gut health
- Expansion of livestock and poultry farming
- Restraints
- High cost of eubiotic formulations
- Regulatory hurdles across different regions
- Limited penetration in developing economies
- Lack of standardized efficacy benchmarks
- Opportunities
- Innovation in multi-strain probiotic blends
- R&D in microbiome-based feed solutions
- Rising organic and antibiotic-free meat demand
- Expansion into aquaculture and companion animals
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Eubiotics Market, By Type, 2021 - 2031 (USD Million)
- Probiotics
- Lactobacilli
- Bifidobacteria
- Others
- Prebiotics
- Inulin
- Fructo-oligosaccharides
- Galacto-oligosaccharides
- Others
- Organic Acids
- Essential Oils
- Probiotics
- Eubiotics Market, By Animal Type, 2021 - 2031 (USD Million)
- Ruminant
- Poultry
- Swine
- Aquaculture
- Others
- Eubiotics Market, By Form, 2021 - 2031 (USD Million)
- Liquid
- Solid
- Eubiotics Market, By End Use, 2021 - 2031 (USD Million)
- Cattle Feed
- Poultry Feed
- Swine Feed
- Aquatic Feed
- Others
- Eubiotics Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Eubiotics Market, By Type, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- BASF SE
- Cargill Incorporated
- Novozymes
- E. I. du Pont de Nemours and Company
- Kemin Industries Inc
- Lallemand Inc
- Koninklijke DSM NV
- Chr. Hansen Holding AS
- Addcon
- Novus International Inc
- Company Profiles
- Analyst Views
- Future Outlook of the Market